B

Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315

Watchlist Manager
Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315
Watchlist
Price: 5.6 HKD -2.78% Market Closed
Market Cap: 2.2B HKD
Have any thoughts about
Biocytogen Pharmaceuticals Beijing Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Biocytogen Pharmaceuticals Beijing Co Ltd stock under the Base Case scenario is 9.74 HKD. Compared to the current market price of 5.6 HKD, Biocytogen Pharmaceuticals Beijing Co Ltd is Undervalued by 43%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
9.74 HKD
Undervaluation 43%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation Backtest
Biocytogen Pharmaceuticals Beijing Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Biocytogen Pharmaceuticals Beijing Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Biocytogen Pharmaceuticals Beijing Co Ltd?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Biotechnology Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Biocytogen Pharmaceuticals Beijing Co Ltd

Provide an overview of the primary business activities
of Biocytogen Pharmaceuticals Beijing Co Ltd.

What unique competitive advantages
does Biocytogen Pharmaceuticals Beijing Co Ltd hold over its rivals?

What risks and challenges
does Biocytogen Pharmaceuticals Beijing Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide P/S
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide P/E
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide P/OCF
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide P/FCFE
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide P/B
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide EV/S
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide EV/GP
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide EV/EBITDA
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide EV/EBIT
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide EV/OCF
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide EV/FCFF
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide EV/IC
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Show me price targets
for Biocytogen Pharmaceuticals Beijing Co Ltd made by professional analysts.

What are the Revenue projections
for Biocytogen Pharmaceuticals Beijing Co Ltd?

How accurate were the past Revenue estimates
for Biocytogen Pharmaceuticals Beijing Co Ltd?

What are the Net Income projections
for Biocytogen Pharmaceuticals Beijing Co Ltd?

How accurate were the past Net Income estimates
for Biocytogen Pharmaceuticals Beijing Co Ltd?

What are the EPS projections
for Biocytogen Pharmaceuticals Beijing Co Ltd?

How accurate were the past EPS estimates
for Biocytogen Pharmaceuticals Beijing Co Ltd?

What are the EBIT projections
for Biocytogen Pharmaceuticals Beijing Co Ltd?

How accurate were the past EBIT estimates
for Biocytogen Pharmaceuticals Beijing Co Ltd?

Compare the revenue forecasts
for Biocytogen Pharmaceuticals Beijing Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Biocytogen Pharmaceuticals Beijing Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Biocytogen Pharmaceuticals Beijing Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Biocytogen Pharmaceuticals Beijing Co Ltd compared to its peers.

Compare the P/E ratios
of Biocytogen Pharmaceuticals Beijing Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Biocytogen Pharmaceuticals Beijing Co Ltd with its peers.

Analyze the financial leverage
of Biocytogen Pharmaceuticals Beijing Co Ltd compared to its main competitors.

Show all profitability ratios
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide ROE
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide ROA
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide ROIC
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide ROCE
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide Gross Margin
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide Operating Margin
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide Net Margin
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide FCF Margin
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Show all solvency ratios
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide D/E Ratio
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide D/A Ratio
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide Interest Coverage Ratio
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide Altman Z-Score Ratio
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide Quick Ratio
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide Current Ratio
for Biocytogen Pharmaceuticals Beijing Co Ltd.

Provide Cash Ratio
for Biocytogen Pharmaceuticals Beijing Co Ltd.

What is the historical Revenue growth
over the last 5 years for Biocytogen Pharmaceuticals Beijing Co Ltd?

What is the historical Net Income growth
over the last 5 years for Biocytogen Pharmaceuticals Beijing Co Ltd?

What is the current Free Cash Flow
of Biocytogen Pharmaceuticals Beijing Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Biocytogen Pharmaceuticals Beijing Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Biocytogen Pharmaceuticals Beijing Co Ltd

Balance Sheet Decomposition
Biocytogen Pharmaceuticals Beijing Co Ltd

Current Assets 766.1m
Cash & Short-Term Investments 419.9m
Receivables 184.6m
Other Current Assets 161.7m
Non-Current Assets 1.7B
Long-Term Investments 179.3m
PP&E 1.4B
Intangibles 24.4m
Other Non-Current Assets 67.5m
Current Liabilities 572.6m
Accounts Payable 117.8m
Other Current Liabilities 454.8m
Non-Current Liabilities 1.1B
Long-Term Debt 328.6m
Other Non-Current Liabilities 791.4m
Efficiency

Earnings Waterfall
Biocytogen Pharmaceuticals Beijing Co Ltd

Revenue
800.6m CNY
Cost of Revenue
-224.4m CNY
Gross Profit
576.2m CNY
Operating Expenses
-715.9m CNY
Operating Income
-139.8m CNY
Other Expenses
-104.1m CNY
Net Income
-243.8m CNY

Free Cash Flow Analysis
Biocytogen Pharmaceuticals Beijing Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Biocytogen Pharmaceuticals Beijing Co Ltd's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
Negative ROIC
28/100
Profitability
Score

Biocytogen Pharmaceuticals Beijing Co Ltd's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Biocytogen Pharmaceuticals Beijing Co Ltd's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Long-Term Solvency
Short-Term Solvency
41/100
Solvency
Score

Biocytogen Pharmaceuticals Beijing Co Ltd's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Biocytogen Pharmaceuticals Beijing Co Ltd

Wall Street analysts forecast Biocytogen Pharmaceuticals Beijing Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Biocytogen Pharmaceuticals Beijing Co Ltd is 15.17 HKD with a low forecast of 13.62 HKD and a high forecast of 17.06 HKD.

Lowest
Price Target
13.62 HKD
143% Upside
Average
Price Target
15.17 HKD
171% Upside
Highest
Price Target
17.06 HKD
205% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Biocytogen Pharmaceuticals Beijing Co Ltd?

Click here to dive deeper.

Dividends

Biocytogen Pharmaceuticals Beijing Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for Biocytogen Pharmaceuticals Beijing Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Biocytogen Pharmaceuticals Beijing Co Ltd

Country

China

Industry

Biotechnology

Market Cap

2.2B HKD

Dividend Yield

0%

Description

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. manufactures biological products and provides related biological services. The company is headquartered in Beijing, Beijing. The company went IPO on 2022-09-01. The firm operates two business segments. The Drug Development Business segment is mainly engaged in the research and development of oncology and autoimmune disease treatments, as well as antibody development. The Preclinical Research Service segment is mainly engaged in gene editing, preclinical pharmacological efficacy evaluation and model animal sales.

Contact

BEIJING
Beijing
12 Baoshen South Street, Daxing Bio-Medicine Industry Park, Daxing District
www.biocytogen.com.cn

IPO

2022-09-01

Employees

-

Officers

Chairman of the Board, CEO & GM
Dr. Yuelei Shen Ph.D.
Executive Director
Dr. Jian Ni
Senior Operation Director of Animal Center & Executive Director
Dr. Haichao Zhang
CFO & Deputy GM
Mr. Bin Liu
Chief Scientific Officer & Deputy GM
Dr. Yi Yang
VP of Marketing & Deputy GM
Dr. Chaoshe Guo
Show More
Director of Human Resources & Supervisor
Ms. Chunli Sun
Chairman of the Supervisory Committee & Director of the President's Office
Ms. Yan Li
Deputy GM & CEO of Biocytogen Boston Corp.
Dr. Qingcong Lin
Deputy GM, Joint Company Secretary & Chief Secretariat Officer
Mr. Yongliang Wang
Show Less

See Also

Discover More
What is the Intrinsic Value of one Biocytogen Pharmaceuticals Beijing Co Ltd stock?

The intrinsic value of one Biocytogen Pharmaceuticals Beijing Co Ltd stock under the Base Case scenario is 9.74 HKD.

Is Biocytogen Pharmaceuticals Beijing Co Ltd stock undervalued or overvalued?

Compared to the current market price of 5.6 HKD, Biocytogen Pharmaceuticals Beijing Co Ltd is Undervalued by 43%.

Back to Top